PREDICT: Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease
Study Details
Study Description
Brief Summary
It is assumed that gut inflammation and lesions characterizing flares of Crohn's disease (CD) result from an aberrant T-cell mediated immune responses characterized by a complex balance between peripheral and lamina propria regulatory and effector T cell subsets. Because most of CD patients who undergo a surgery experienced a postoperative endoscopic recurrence of the disease (70 % at one year) leading to a clinical recurrence (10 % per year), the "model" of postoperative recurrence in CD represents a privileged situation that mimicks what happens in the gut of CD patients in clinical remission before the occurrence of further flares. It is likely that the same factors which underlie the immunopathogenesis of CD at its early stages also contribute to disease recurrence in the postoperative setting. Indeed, the postoperative state is performed for intent of disease remission and this situation represents probably an ideal setting to investigate the dynamics of most of T cell subsets in the peripheral and mucosal compartments because one may argue that removal of the diseased segment of bowel resets the disease to its earliest phases, providing an interesting window to better understand which T cell subsets predispose to disease recurrence.
That is the reason why this model will be used in the present project i) to understand better the immunopathogenesis of CD relapse; ii) to identify novel and promising immune cell-associated biomarkers capable to predict relapse of the disease and finally iii) to identify potential specific therapeutic target associated with T cell subsets involved in the initiation of disease.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Postoperative endoscopic recurrence Patients with a diagnosis of Crohn's disease who undergo an ileo-colonic curative resection |
Other: blood sample
|
Outcome Measures
Primary Outcome Measures
- Postoperative endoscopic recurrence, assessed by a Rutgeerts 's score > i1, over the one-year post-surgery follow-up [at one year]
Rutgeerts 's score > i1
Secondary Outcome Measures
- proportion of T cell subsets in the arm of patients who will experience a recurrence and those who will not. [at 3 months before relapse]
- number of T cell subsets in the arm of patients who will experience a recurrence and those who will not. [at 3 months before relapse]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Aged over 18 years
-
Men or non-pregnant women
-
Patients with a diagnosis of Crohn's disease who undergo an ileo-colonic curative resection
-
No change of the postoperative treatment before assessing an endoscopic recurrence during the one-year post surgery follow-up period
-
Informed consent given
Exclusion Criteria:
-
Pregnancy
-
History of disease, including mental/emotional disorder, that might interfere with their participation in the study
-
Inability to comply with the protocol requirements
-
Inability to fill in the diary cards
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Service d'Hépato-Gastroentérologie Centre hospitalier Lyon Sud Hospices Civils de Lyon | Pierre Benite | France |
Sponsors and Collaborators
- Hospices Civils de Lyon
Investigators
- Principal Investigator: Stéphane NANCEY, MD, Service d'Hépato-Gastroentérologie Centre hospitalier Lyon Sud Hospices Civils de Lyon
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2010-616